Enzyme coupled receptors, receptor tyrosine kinases - Lecture 24 Flashcards

1
Q

What is known about Tyrosine phosphorylation?

A
  • protein phosphorylation discovered in 1906
  • first evidence for tyrosine kinase in 1979
  • human genome was fully sequenced in 2001, and revealed that there are ~90 tyrosine kinases
    Controls the following:
    -growth factor signalling (and oncogenesis)
  • cell adhesion, spreading, migration and shape
  • cell cycle control
  • gene regulation and transcription
  • stimulation of glucose uptake (insulin)
  • angiogenesis (sprouting of new blood vessels)
  • etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the receptor tyrosine kinase (RTK) families

A
  • transmembrane proteins with extracellular ligand binding domains
  • their carboxyl-terminal domains either have intrinsic enzymatic activity or are directly associated with cytosolic enzymes
  • each subunit of an RTK has one transmembrane spanning domain
  • most inactive RTKs are monomers
  • ligand binding causes a conformational changes, which brings two internal kinase domains together
  • exception: insulin receptor family where receptors are dimers (pre-dimerized) - have an extra level of control to maintain them in inactive state in absence of ligand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the insulin receptor activation

A
  • purified insulin receptors embedded into nanodiscs (nanoscale disc-shaped membrane patches)
  • visualized by single-particle electron microscopy
  • extra polypeptide loop over ATP binding pocket (block - without insulin, does not signal)
  • no insulin = intracellular domains are very close together, kinase domains are very far apart
  • in presence of insulin = extracellular domain moves, causes the kinase domains to come together to interact and activate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the point of cell surface receptors?

A

respond to low concentrations of ligand
signal - reception - transduction - response (need amplification)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are RTK ligands?

A

receptor tyrosine kinases (RTKs) are activated by two types of ligands:
1. cell surface bounds ligands
2. secreted growth factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are cell surface bound ligands?

A
  • RTK ligands
  • ephrins which activate ephrin receptors
  • ‘bidirectional signalling’: ligand engagement of the receptor can result in signalling from the target cell to the signalling cell
  • the signal is not only sent to the target cell but is also sent back to the signalling cell (ephrins bind to other kinases and stimulate signalling)
  • regulate: angiogenesis, and axon guidance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are examples of secreted growth factors?

A
  • epidermal growth factor (EGF)
  • platelet derived growth factor (PDGF)
  • insulin, insulin-like growth factor (IGF-1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are secreted growth factors?

A
  • RTK ligands
  • dimeric ligand: e.g. PDGF is a covalently linked dimer with two distinct receptor binding domains (sties)
  • PDGF can dimerize two adjacent PDGF receptors to initiate intracellular signalling
  • signal molecule binds two separate receptors to bring them together to dimerize
  • monomeric ligands: e.g. EGF; dimerization orients the internal kinase domains: phosphorylation of Tyr residues in C - tail of both receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the receptor kinase activation

A
  • dimer formation brings the kinase domains of each cytosolic receptor tail into contact with the other (dimerization)
  • transactivation: this activates the kinases to phosphorylate the adjacent tail on several tyrosines: receptor autophosphorylation (one receptor phosphorylates the tyrosines of the other and vice-versa = trans-activation/ trans-phosphorylation/ auto-phosphorylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the receptor tyrosine kinase substrate recruitment

A
  • each phosphorylated tyrosine serves as a specific docking site for several intracellular signalling proteins, via a SH2 interaction domain - bring proteins together in a complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are docking sites?

A

Grb2 recognizes a specific phosphorylated tyrosine on the activated receptor by means of an SH2 domain and recruits Sos
(this is an example - other proteins with SH2 domains can also bind)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do RTKs activate Ras?

A
  • Grb-2: growth factor receptor binding protein-2 (has SH2 domain which binds the activated RTK, and also has SH3 domain - this binds Ras-GEF also called Sos)
  • Sos: Son of Sevenless (Guanine nucleotide exchange factor that stimulates GDP to GTP exchange on Ras)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where does ‘Src Homology Domain’ (SH) nomenclature come from?

A

Modular protein interaction domains were first identified in the tyrosine kinase Src. These domains are referred to as Src homology domains (SH)
- SH1 domain: tyrosine kinase domain (not called SH1 anymore)
- SH2 domain: recognizes specific phosphotyrosine motifs
- SH3 domain: binds to proline rich domains in intracellular proteins
- Some SH2 (and/or SH3) containing proteins: enzymes, adaptors, scaffold proteins, and signal regulators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Ras superfamily of small GTPases

A

Ras, Rho, Rab, Arf, Ran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the activation of the MAP kinase cascade (downstream of Ras)

A
  1. Ras activates MAP-kinase-kinase-kinase (e.g. Raf)
  2. Raf phosphorylates MAP-kinase-kinase (e.g MEK)
  3. MEK phosphorylates MAP-kinase (e.g. MAPK:ERK1/2 (MAP ERK kinase)
    - MAPK phosphorylates cytoplasmic proteins or translocates to nucleus and phosphorylates transcription factors
    MAPK: mitogen activated protein kinase
    ERK: extracellularly regulated kinase
    - cascade leads to genetic changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the compartmentalization of MAPK signalling by scaffolds

A

Mammalian cells utilize strategies to limit cross talk between MAP-kinase signalling pathways and to compartmentalize signalling cascade

17
Q

What are scaffold proteins?

A

One strategy is to utilize scaffold proteins to hold the three kinases that comprise the MAP-kinase cascade in a molecular complex
- the scaffold strategy allows for the precise recruitment and regulation of MAP kinases in cellular compartments pre-determined by the both the nature of the scaffold and the receptor activating signal

18
Q

Describe the EGFR signalling in carcinogenesis

A

Proto-oncogene:
- a normal gene which, when altered by mutation, becomes an oncogene that can contribute to cancer
- may have many different functions in the cell - can provide signals that lead to cell division - regulate programmed cell death (apoptosis)
Oncogene:
- a gene having the potential to cause a normal cell to become cancerous (EGF receptor)
- 85-90% of lung cancers are non-small cell lung cancer (NSCLC)
- EGFR over-expressed
- EGFR mutations (exons 18-21): encodes EGFR kinase domain: increase in kinase activity, hyper-activation of downstream pro-survival signalling pathways
- over expression cells express so many receptors - don’t need ligands, they bump into each other spontaneously and signal the cascade activation
MAPK
- phosphorylates cytoplasmic proteins or translocates to the nucleus and phosphorylates (regulates) transcription factors
- e.g. Ets (E-26) and Jun (from Japanese ju-nana, meaning 17, short for avian sarcoma virus 17)
STAT
- signal transducer and activator of transcription (transcription factor)
- physically associates with receptor phosphorylated, dimerized, dissociates and goes straight to the nucleus
PI3K
- phosphoinositide 3-kinase
AKT
- promotes cell survival
mTOR
- mammalian target of rapamycin (serine-threonine kinase): central regulator of cell metabolism, growth, proliferation and survival
PTEN
- phosphatase: antagonizes the PI3’ kinase/AKT pathway

19
Q

Describe EGFR signalling

A

PIP2: phosphatidylinositol 4, 5 bisphosphate
PIP3: phosphatidylinositol 3, 4 triphosphate
PTEN: phosphatase and tensin homolog
PDK-1: Phosphoinositide-dependent kinase-1
AKT/PKB: protein kinase B
PH: pleckstrin homology domain (binds to PIP3)

20
Q

Describe EGFR targeted therapy: monoclonal antibodies

A

FOLFOX-4:
- standard chemotherapy
- folinic acid, fluorouracil, and oxaliplatin
Cenuximab:
- monoclonal antibody
- binds to the extracellular region of the EGFR
- antagonizes ligand binding
- stimulates EGFR internalization and degradation
*antibodies to EGF receptor - not just control vs treatment - one gets gold standard treatment, other gets this + something

21
Q

Describe insulin receptor signalling

A

Insulin receptor was activated, does not become docking site, phosphorylates IRS
IRS: insulin receptor substrate (becomes docking site, has lots of tyrosine)
aPKC: atypical protein kinase C
GSK3: glycogen synthase kinase 3
GS: glycogen synthase
AS160: Akt substrate of 160 kDa